This inventor holds 30 USPTO granted patents and 2 published patent applications, primarily in Adenoviral Vector Technology. Top assignees: Cell Genesys, Inc., Calydon, Inc., Cold Genesys, Inc.. Active years: 1997-2011.
Location History:
- Palo Alto, CA (US) (1997 - 2009)
- Del Mar, CA (US) (2006 - 2011)
Company Filing History:
16 out of 78Â 
10 out of 10Â 
2 out of 2Â Years Active: 1997-2011
Areas of Expertise:
Title: Daniel R Henderson: Pioneering Innovations and Milestones
Introduction:
Throughout his illustrious career, Daniel R Henderson has made significant contributions to the field of innovation and patents. Based in Palo Alto, CA (US), Henderson has been recognized for his groundbreaking work, which has not only revolutionized existing industries but has also opened up new possibilities. With a strong background and a track record of 30 patents, Henderson continues to push the boundaries of scientific discovery and technological advancements.
Latest Patents:
One of Henderson's recent groundbreaking patents is titled "Adenovirus Vectors Containing Cell Status-Specific Response Elements and Methods of Use Thereof." These vectors incorporate cell status-specific transcriptional regulatory elements, enabling precise regulation of gene expression in response to a cell's physiological or environmental state. Compositions and host cells consisting of these vectors have also been developed, along with methods of their application. This invention has immense potential for gene therapy, personalized medicine, and targeted treatments.
Career Highlights:
Over the course of his career, Henderson has achieved numerous milestones, consistently pushing the boundaries of innovation. He has demonstrated a particular expertise in gene therapy and viral vectors, addressing various challenges and developing novel solutions. Henderson's inventions have the potential to significantly impact the fields of biotechnology, pharmaceuticals, and medical research.
Collaborations:
Henderson has collaborated with renowned experts, further augmenting his innovative ventures. Notably, he has worked with Eric R Schuur and De-Chao Yu, establishing fruitful partnerships that have resulted in cutting-edge advancements and groundbreaking patents. Collaborations like these have allowed Henderson to leverage the collective knowledge and expertise of esteemed colleagues, shaping the landscape of innovation further.
Conclusion:
Daniel R Henderson's career is marked by groundbreaking inventions and numerous patents. His innovative approach and ability to address complex challenges have revolutionized existing industries and opened new pathways for scientific exploration. Henderson's latest patents in the field of adenovirus vectors demonstrate his dedication to pushing the boundaries of personalized medicine and gene therapy. With his drive for innovation and fruitful collaborations, Henderson continues to make significant contributions, improving lives and driving progress in fields of exceptional importance.